Christopher D. Payne

4.4k citations

45 papers · 3.5k indexed · 1 hit paper · h-index 29

Impact in

Internal Medicine top 0.5%
- Venous Thromboembolism Diagnosis and Management
Cardiology and Cardiovascular Medicine top 0.5%
- Antiplatelet Therapy and Cardiovascular Diseases
- Acute Myocardial Infarction Research
- Atrial Fibrillation Management and Outcomes

Papers in

Cardiology and Cardiovascular Medicine 28
- Antiplatelet Therapy and Cardiovascular Diseases 28
- Atrial Fibrillation Management and Outcomes 7
Internal Medicine 4

Co-authors: Kenneth J. Winters John T. Brandt Joseph A. Jakubowski Daniel E. Salazar Nagy A. Farid David S. Small C. Steven Ernest Hideo Naganuma
Journals: Journal of Cardiovascular Pharmacology (5 papers)British Journal of Clinical Pharmacology (4 papers)Platelets (4 papers)Advances in Therapy (3 papers)Annals of the Rheumatic Diseases (2 papers)
Partner nations: United States United Kingdom Japan

In The Last Decade

Christopher D. Payne

43 papers receiving 3.4k citations

Hit Papers

align trajectories log scale

Common polymorphisms of CYP2C19 and CYP2C9 affect the pharmacokinetic and pharmacodynamic response to clopidogrel but not prasugrel 2007 · 553 citations

Peers

Countries citing papers authored by Christopher D. Payne

Since Specialization

Citations

This map shows the geographic impact of Christopher D. Payne's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher D. Payne with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher D. Payne more than expected).

Fields of papers citing papers by Christopher D. Payne

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christopher D. Payne. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher D. Payne. The network helps show where Christopher D. Payne may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Christopher D. Payne, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Christopher D. Payne Line = papers co-authored together Christopher D. Payne links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Pharmacokinetic Comparability and Safety Between Original and Citrate-Free Mirikizumab Formulations for Subcutaneous Injections: Results from Three Clinical Trials Advances in Therapy ·Yuki Otani, Brian G. Feagan, Geert D’Haens, Rodrigo Escobar, Nathan Morris, Christopher D. Payne, Michelle Lopes, Franciele Caroline Gorges	2025	0
2	Subcutaneous Injection Site Pain of Formulation Matrices Pharmaceutical Research ·Matthias Albani, 壮史米坂, Mayara Vello, Dong-Ik Oh, Christopher D. Payne, Wen Xu, David S. Collins, O. Hrabovska	2021	28
3	Pharmacokinetic and Pharmacodynamic Effects of Prasugrel in Healthy Korean Males Journal of Cardiovascular Pharmacology ·Kyung‐Sang Yu, Kyung Woo Park, Ronan P. Kelly, Namyi Gu, Christopher D. Payne, David S. Small, F Roreat, Yakun Yang, Philippe Pinton	2013	7
4	A Phase 1 Study of Prasugrel in Subjects with Sickle Cell Disease: Effects on In Vivo Markers of Platelet Activation and of Coagulation Blood ·Joseph A. Jakubowski, Chunmei Zhou, David S. Small, Kenneth J. Winters, D. Richard Lachno, Andrew L. Frelinger, Jo Howard, Stipo Jurčević, Christopher D. Payne	2011	2
5	A Comparison of the VerifyNow P2Y12 Point-of-Care Device and Light Transmission Aggregometry to Monitor Platelet Function with Prasugrel and Clopidogrel: An Integrated Analysis Journal of Cardiovascular Pharmacology ·Joseph A. Jakubowski, Ying G. Li, David S. Small, Christopher D. Payne, Molly Tomlin, Junxiang Luo, Kenneth J. Winters	2010	39
6	Pharmacodynamics and pharmacokinetics of single doses of prasugrel 30 mg and clopidogrel 300 mg in healthy chinese and white volunteers: An open-label trial Clinical Therapeutics ·David S. Small, Christopher D. Payne, Prajakti A. Kothare, Eunice Yuen, Fanni Natanegara, 保志榊原, Joseph A. Jakubowski, D. Richard Lachno, Ying G. Li, Kenneth J. Winters, Nagy A. Farid, Lan Ni, Daniel E. Salazar, Molly Tomlin, Ronan P. Kelly	2010	39
7	Integrated Analysis of Pharmacokinetic Data Across Multiple Clinical Pharmacology Studies of Prasugrel, a New Thienopyridine Antiplatelet Agent The Journal of Clinical Pharmacology ·David S. Small, Ying G. Li, C. Steven Ernest, Maysing H Yang, Nagy A. Farid, Christopher D. Payne, Kenneth J. Winters, Shashank Rohatagi, Lan Ni	2010	29
8	Prasugrel pharmacokinetics and pharmacodynamics in subjects with moderate renal impairment and end-stage renal disease Journal of Clinical Pharmacy and Therapeutics ·D. S. Small, Rebecca E. Wrishko, C. Steven Ernest, Lan Ni, Kenneth J. Winters, Nazar Farid, B.E. Ouali, John T. Brandt, Daniel E. Salazar, Helen Beiser, Keri A. Kles, Christopher D. Payne	2009	61
9	The pharmacokinetics and pharmacodynamics of prasugrel in healthy Chinese, Japanese, and Korean subjects compared with healthy Caucasian subjects European Journal of Clinical Pharmacology ·David S. Small, Prajakti A. Kothare, Eunice Yuen, D. Richard Lachno, Ying G. Li, Kenneth J. Winters, Nagy A. Farid, Lan Ni, Joseph A. Jakubowski, Daniel E. Salazar, Vivian T. Thieu, Christopher D. Payne	2009	55
10	Pharmacokinetics and pharmacodynamics of prasugrel in subjects with moderate liver disease Journal of Clinical Pharmacy and Therapeutics ·D. S. Small, Nazar Farid, B.E. Ouali, C. Steven Ernest, Kenneth J. Winters, Daniel E. Salazar, Christopher D. Payne	2009	23
11	Effects of the Proton Pump Inhibitor Lansoprazole on the Pharmacokinetics and Pharmacodynamics of Prasugrel and Clopidogrel The Journal of Clinical Pharmacology ·David S. Small, Nagy A. Farid, Christopher D. Payne, Govinda Weerakkody, Ying G. Li, John T. Brandt, Daniel E. Salazar, Kenneth J. Winters	2008	245
12	The use of the VerifyNow P2Y12 point-of-care device to monitor platelet function across a range of P2Y12 inhibition levels following prasugrel and clopidogrel administration Thrombosis and Haemostasis ·Christopher D. Payne, Ying G. Li, John T. Brandt, David S. Small, Nagy A. Farid, Daniel E. Salazar, Kenneth J. Winters, Joseph A. Jakubowski	2008	99
13	Clopidogrel poor responders: An objective definition based on Bayesian classification Platelets ·Govinda J. Weerakkody, John T. Brandt, Christopher D. Payne, Joseph A. Jakubowski, Hideo Naganuma, Kenneth J. Winters	2007	24
14	Common polymorphisms of CYP2C19 and CYP2C9 affect the pharmacokinetic and pharmacodynamic response to clopidogrel but not prasugrel Journal of Thrombosis and Haemostasis ·John T. Brandt, Sandra Close, Stephen J. Iturria, Christopher D. Payne, Nazar Farid, C. Steven Ernest, D. Richard Lachno, Daniel E. Salazar, Kenneth J. Winters Hit paper breakdown →	2007	553
15	Increased Active Metabolite Formation Explains the Greater Platelet Inhibition With Prasugrel Compared to High-dose Clopidogrel Journal of Cardiovascular Pharmacology ·Christopher D. Payne, Aditya Sakalkale, David S. Small, C. Steven Ernest, Nagy A. Farid, Joseph A. Jakubowski, John T. Brandt, Daniel E. Salazar, Kenneth J. Winters	2007	135
16	A comparison of the antiplatelet effects of prasugrel and high-dose clopidogrel as assessed by VASP-phosphorylation and light transmission aggregometry Thrombosis and Haemostasis ·Christopher D. Payne, Ying G. Li, Nagy A. Farid, John T. Brandt, David S. Small, Daniel E. Salazar, Kenneth J. Winters, Joseph A. Jakubowski	2007	66
17	Prasugrel achieves greater inhibition of platelet aggregation and a lower rate of non-responders compared with clopidogrel in aspirin-treated patients with stable coronary artery disease European Heart Journal ·Tomas Jernberg, Christopher D. Payne, Kenneth J. Winters, Christelle Darstein, John T. Brandt, Joseph A. Jakubowski, Hideo Naganuma, Agneta Siegbahn, Lars Wallentin	2006	424
18	The Platelet Inhibitory Effects and Pharmacokinetics of Prasugrel After Administration of Loading and Maintenance Doses in Healthy Subjects Journal of Cardiovascular Pharmacology ·Joseph A. Jakubowski, Christopher D. Payne, John T. Brandt, Govinda Weerakkody, Nagy A. Farid, David S. Small, Hideo Naganuma, W. R. Lovic, Kenneth J. Winters	2006	72
19	Effects of gender, age, diabetes mellitus and renal and hepatic impairment on tadalafil pharmacokinetics British Journal of Clinical Pharmacology ·S. Thomas Forgue, Diane L. Phillips, Alun Bedding, Christopher D. Payne, Romuald Choteau, Beverley Patterson, Rebecca E. Wrishko, Malcolm I. Mitchell	2006	48
20	Tadalafil pharmacokinetics in healthy subjects British Journal of Clinical Pharmacology ·S. Thomas Forgue, Beverley Patterson, Alun Bedding, Christopher D. Payne, Diane L. Phillips, Rebecca E. Wrishko, Malcolm I. Mitchell	2005	226

About Christopher D. Payne

Christopher D. Payne is a scholar working on Cardiology and Cardiovascular Medicine, Internal Medicine, Pharmacology, Pharmacology and Genetics, having authored 45 papers that have together received 3.5k indexed citations. Recurring topics across this work include Antiplatelet Therapy and Cardiovascular Diseases (28 papers), Lipoproteins and Cardiovascular Health (14 papers), Inflammatory mediators and NSAID effects (10 papers), Atrial Fibrillation Management and Outcomes (7 papers), Diabetes Treatment and Management (6 papers), Platelet Disorders and Treatments (5 papers), Pharmacogenetics and Drug Metabolism (5 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (4 papers). The work is most often cited by research in Internal Medicine (777 citations), Cardiology and Cardiovascular Medicine (2.8k citations), Endocrinology, Diabetes and Metabolism (635 citations), Pharmacology (631 citations) and Surgery (1.3k citations). Christopher D. Payne has collaborated with scholars based in United States, United Kingdom and Japan. Frequent co-authors include Kenneth J. Winters, John T. Brandt, Joseph A. Jakubowski, Daniel E. Salazar, Nagy A. Farid, David S. Small, C. Steven Ernest, Hideo Naganuma, Nazar Farid and Ying G. Li. Their work appears in journals such as Journal of Cardiovascular Pharmacology, British Journal of Clinical Pharmacology, Platelets, Advances in Therapy and Annals of the Rheumatic Diseases.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact